{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/palliative-care-oral/management/mouth-ulcers-mucositis/","result":{"pageContext":{"chapter":{"id":"ceee9eeb-7174-5047-ae7d-904f58b5e2df","slug":"mouth-ulcers-mucositis","fullItemName":"Scenario: Mouth ulcers and mucositis","depth":2,"htmlHeader":"<!-- begin field 3726356f-c0f0-4218-96f9-5d580356a224 --><h2>Scenario: Mouth ulcers and mucositis</h2><!-- end field 3726356f-c0f0-4218-96f9-5d580356a224 -->","summary":"Covers the management of patients with aphthous ulcers, oral herpes simplex infection, chemotherapy- or radiotherapy-induced mucositis, neutropenic ulcers, and malodour from malignant tumours in the oral cavity.","htmlStringContent":"<!-- begin item 9e4ec6d4-1af6-49db-9f2c-1deb7b024e31 --><!-- begin field 73246e25-ad52-4c5e-a4bb-acbc015b3128 --><p>From age 16 years onwards.</p><!-- end field 73246e25-ad52-4c5e-a4bb-acbc015b3128 --><!-- end item 9e4ec6d4-1af6-49db-9f2c-1deb7b024e31 -->","topic":{"id":"ba62b1ab-ffea-5bce-8fd6-6127df66395a","topicId":"dc5a4c25-cbc0-4da8-9263-892c0ddb29be","topicName":"Palliative care - oral","slug":"palliative-care-oral","lastRevised":"Last revised in October 2018","chapters":[{"id":"92b78ff5-a7a3-533b-9fad-3812221a3e70","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"e63cc0ed-d679-5b57-bd5d-a0fffc2bb1c5","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"0d446cc8-8026-59f2-8be3-a3df05f54690","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"94667ccb-b451-5743-aeb8-44fbce6caf13","slug":"changes","fullItemName":"Changes"},{"id":"d267c387-0c44-5636-b186-efd35314ddb7","slug":"update","fullItemName":"Update"}]},{"id":"b1959eca-8652-570a-bf43-e03f35359c72","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"190545c6-de91-566d-97ca-ec507ec5ffd5","slug":"goals","fullItemName":"Goals"},{"id":"51115a15-fe56-57ee-99b3-cdd5c4f1c6a0","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"4d5ef3b4-1232-5943-8fad-b29aa5998488","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"80c55ca1-b9c4-5b9f-9bc7-c6c5fd42df42","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"909bc973-bd01-5f89-8719-11278e3eec78","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"6f3efef7-3ed5-5013-9a70-606c9dbe0943","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"78d7fe5a-a1b6-58ed-9302-ad88f95d8db5","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"f6c72ae5-a1db-5d81-b680-40d5e677f0e7","slug":"causes","fullItemName":"Causes"},{"id":"c6626f56-2d11-59eb-aaa1-7df1a7759a57","slug":"oral-problems","fullItemName":"Oral problems"},{"id":"047eef6e-58db-5c3e-bbc9-a5b23171e78a","slug":"prevalence","fullItemName":"Prevalence"},{"id":"efa65b1a-1a58-5453-b232-dcb7a4ad4533","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"87dda915-3779-5f4a-afd9-f77577bf772b","slug":"complications","fullItemName":"Complications"}]},{"id":"8d836099-7e31-5881-bb05-20f08d446d0b","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"b391498b-1e1b-5dcb-a663-5c2acc77475b","slug":"history","fullItemName":"History"},{"id":"b7bc660c-5027-59c4-b81e-daabd0aae4ef","slug":"examination","fullItemName":"Examination"},{"id":"01753f6e-7f5f-5eea-a4f5-860d02375047","slug":"investigations","fullItemName":"Investigations"}]},{"id":"b7921f28-c4d4-513c-9424-c072661841bd","fullItemName":"Management","slug":"management","subChapters":[{"id":"8e4de9d8-84d5-5ccb-a53b-b45928ebc3e0","slug":"assessment","fullItemName":"Scenario: Assessment"},{"id":"b1f750e8-79b4-5942-abd9-85bc539f3606","slug":"prevention","fullItemName":"Scenario: Prevention"},{"id":"1fcf7fd1-2915-57d3-b741-40d617974983","slug":"dry-mouth","fullItemName":"Scenario: Dry mouth"},{"id":"89366510-b0a8-56fc-bf18-765bf712040e","slug":"oral-pain","fullItemName":"Scenario: Oral pain"},{"id":"dcda2b7f-7a28-5b54-81d7-74ca0a1293ac","slug":"oral-candida-infection","fullItemName":"Scenario: Oral candida infection"},{"id":"ceee9eeb-7174-5047-ae7d-904f58b5e2df","slug":"mouth-ulcers-mucositis","fullItemName":"Scenario: Mouth ulcers and mucositis"},{"id":"ceebbe2f-4f2d-5b69-8484-69a7b63d4155","slug":"halitosis-excessive-salivation-altered-taste","fullItemName":"Scenario: Halitosis, excessive salivation and altered taste"},{"id":"ae4a6023-826b-5bf3-8610-183b69c705c0","slug":"end-of-life-care","fullItemName":"Scenario: End of life care"}]},{"id":"f953784c-8686-5a90-92cd-60d68dbd6845","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"26f08b6c-5b56-5782-8732-efb4b6e713af","slug":"topical-artificial-saliva-saliva-stimulant-products","fullItemName":"Topical artificial saliva and saliva stimulant products"},{"id":"96912fd4-a2b4-50f9-86ed-8bb2e45463c5","slug":"oral-pilocarpine","fullItemName":"Oral pilocarpine"},{"id":"c8127148-af88-5ea4-860a-50fcf5aac054","slug":"topical-antifungals","fullItemName":"Topical antifungals"},{"id":"fff90e93-10dd-553e-82f8-0dfd41609a37","slug":"oral-antifungals","fullItemName":"Oral antifungals"},{"id":"065c7442-bd39-51f9-a981-cdaccb1ba40c","slug":"chlorhexidine","fullItemName":"Chlorhexidine"},{"id":"94720495-b83a-5896-aad4-6fe5a74a5f78","slug":"corticosteroids","fullItemName":"Corticosteroids"},{"id":"1c9aa8fa-0094-5e8d-9745-40f1deb0a4bd","slug":"antivirals","fullItemName":"Antivirals"},{"id":"ccf55d3d-9d86-5178-b7de-efe3554f8ad1","slug":"metronidazole","fullItemName":"Metronidazole"}]},{"id":"e8b50dff-617d-541c-8f6c-32d1cc172ad5","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"49c2337d-75af-5e94-a422-dce3f68c22c5","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"87ab81b8-3331-56e9-97da-8ccde09bb168","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"fcdbc4c2-0265-55de-83ef-890d4a2eb6e8","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"2d5e11b2-f829-5c8a-ba4e-4bd0c552209e","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"4a6cc052-004c-5f0c-83f8-f04899c06292","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"e1ee9217-75fd-57a2-8e67-0f9c468e36c9","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"a6d40f6b-b733-5a56-8b81-ff55062d9bcb","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"b7921f28-c4d4-513c-9424-c072661841bd","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"a5ad6a41-7e8f-5785-82e7-06ed86ad714c","slug":"aphthous-ulcers","fullItemName":"Aphthous ulcers","depth":3,"htmlHeader":"<!-- begin field 0bfa4ea6-535a-4d76-a3ed-db9ae7262a0d --><h3>Aphthous ulcers</h3><!-- end field 0bfa4ea6-535a-4d76-a3ed-db9ae7262a0d -->","summary":null,"htmlStringContent":"<!-- begin item 48b410f1-9b04-463d-b6d0-27da39da4a9f --><!-- begin field 3af28f0f-3d5a-474c-9c30-936d517ed56e --><ul><li>Correct any underlying iron, folate, or vitamin B<sub>12 </sub>deficiency if the prognosis allows.</li><li>Treatment choices should be guided by disease severity (pain), the frequency of flare-ups, and the tolerability of medication.<ul><li><strong>Topical corticosteroids:</strong><ul><li>Hydrocortisone lozenges are best used in the prodromal period, before the ulcer develops.</li><li>Beclometasone spray or betamethasone soluble tablets are more potent and are generally reserved for use when ulceration is extensive, or is at a difficult-to-reach site.</li></ul></li><li><strong>Doxycycline mouthwash </strong>can be used for severe recurrent aphthous ulcers (make up by stirring the contents of a doxycycline 100 mg capsule into 10 mL water and rinsing around in the mouth for 2 to 3 minutes, four times a day and then spitting out).</li><li><strong>Chlorhexidine mouthwash </strong>can be used to prevent secondary bacterial infection.<ul><li>Chlorhexidine gluconate 0.2% mouthwash is used for aphthous ulcers (particularly if it is too painful to brush teeth). It should not be used at the same time as nystatin because it reduces the activity of nystatin.</li></ul></li><li>For management of pain associated with aphthous ulcers, see <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-oral/management/oral-pain/\">Scenario: Oral pain</a>.</li><li>For severe persistent ulceration, seek specialist advice.<ul><li>Persistent and severe ulcers may respond to thalidomide (unlicensed use), but this can only be prescribed under specialist supervision.</li></ul></li></ul></li></ul><!-- end field 3af28f0f-3d5a-474c-9c30-936d517ed56e --><!-- end item 48b410f1-9b04-463d-b6d0-27da39da4a9f -->","subChapters":[{"id":"b91589bd-62c4-501f-b8d4-f4b73c94f824","slug":"basis-for-recommendation-442","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 587a83b3-f350-448a-ae43-2b16f9851bb0 --><h4>Basis for recommendation</h4><!-- end field 587a83b3-f350-448a-ae43-2b16f9851bb0 -->","summary":null,"htmlStringContent":"<!-- begin item 442b2f58-d85a-4aa7-9067-709b97f036ba --><!-- begin field 3e77b3cc-658b-4375-830d-8de487f1ec47 --><p>The recommendations are based on those in the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/aphthous-ulcer/\">Aphthous ulcer</a>.</p><ul><li><strong>Topical corticosteroids: </strong>there are few studies to support their use, but some evidence indicates that they reduce the duration of ulcers and hasten pain relief without causing notable local or systemic adverse reactions [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">Porter and Scully, 2007</a>]. Triamcinolone in an adhesive paste (Adcortyl in Orabase<sup>®</sup>) has been discontinued.</li><li>Doxycycline mouthwash: tetracycline used to be recommended, but because tetracycline capsules are no longer available in the UK, doxycycline capsules are generally used. The instructions on how to make up doxycycline mouthwash and information on potential adverse effects are based on expert opinion. This is an unlicensed indication for doxycycline and is prepared by mixing the contents of a 100 mg capsule of doxycycline with 10 mls of water. The dose is 100 mg in 10 mL four times a day and rinsed around the mouth for 2–3 minutes and then spat out [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">Twycross, 2014</a>].</li><li><strong>Chlorhexidine mouthwash: </strong>some evidence indicates that it reduces the duration and severity of aphthous ulcers [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">Porter and Scully, 2007</a>]. It can stain the plaque on teeth brown.</li></ul><!-- end field 3e77b3cc-658b-4375-830d-8de487f1ec47 --><!-- end item 442b2f58-d85a-4aa7-9067-709b97f036ba -->","subChapters":[]}]},{"id":"c075d87b-ec90-52cd-b11e-a64992c92a2a","slug":"mucositis","fullItemName":"Mucositis","depth":3,"htmlHeader":"<!-- begin field 5c25d908-6f90-4c38-acf6-d68af6f1d365 --><h3>Mucositis</h3><!-- end field 5c25d908-6f90-4c38-acf6-d68af6f1d365 -->","summary":null,"htmlStringContent":"<!-- begin item 82f116c7-d1f5-4caf-bcb0-d138493850ef --><!-- begin field f5915752-1953-446e-9852-f6b625190b64 --><ul><li><a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-oral/management/prevention/#self-care\">Self care</a> of the mouth before, during, and after treatment with chemotherapy or radiotherapy reduces the severity of mucositis and helps prevent secondary infection.</li><li>Seek urgent specialist advice if mucositis is severe as it may limit the person's ability to tolerate chemotherapy or radiotherapy.</li><li>Seek urgent specialist advice if spontaneous gingival bleeding occurs.</li><li>Prevention of secondary infection, oral hygiene, and supportive therapy are very important. For more information, see <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-oral/management/prevention/\">Scenario: Prevention</a>.</li><li>Use ice chips to soothe the affected area.</li><li>Treat any infection (such as candida). See <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-oral/management/oral-candida-infection/\">Scenario: Oral candida infection</a>.</li><li>Avoid spicy and acidic foods (including pineapple chunks and fruit-flavoured ice cubes), sweets, alcohol, tobacco, and hot or fizzy drinks. Advise consumption of soft foods with a low salt content.</li><li>Ensure frequent oral care and use of sterile saline mouth rinsing.</li><li>Avoid acidic mouthwashes.<ul><li>Many non-prescription oral preparations are acidic (for example Listerine<sup>®</sup>, hydrogen peroxide, Plax<sup>®</sup>, glycerine and lemon swabs, lemon/raspberry mousselage, Glandosane<sup>® </sup>aerosol spray) and should not be used, as they are likely to increase oral discomfort.</li></ul></li><li>Morphine may be required for pain.</li></ul><!-- end field f5915752-1953-446e-9852-f6b625190b64 --><!-- end item 82f116c7-d1f5-4caf-bcb0-d138493850ef -->","subChapters":[{"id":"22f72b16-3e1d-5366-96ba-64775e443ddf","slug":"basis-for-recommendation-3a0","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 57b30d80-336c-4e35-8b82-18b2d7d3083c --><h4>Basis for recommendation</h4><!-- end field 57b30d80-336c-4e35-8b82-18b2d7d3083c -->","summary":null,"htmlStringContent":"<!-- begin item 3a03ba12-f0ee-4e52-8bbc-2b769743f376 --><!-- begin field 5369e730-2e2f-467f-8a0c-9b0ee60b5117 --><p>This recommendation is based on expert opinion [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">Davies,&nbsp;2015</a>], and national guidance [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">Royal College of Surgeons of England, 2012</a>].</p><ul><li>There is weak evidence from a Cochrane review that low level laser treatment may reduce the severity of mucositis caused by chemotherapy or radiotherapy. The current evidence does not justify the use of this measure.</li><li><strong>There is no specific treatment for oral mucositis, </strong>although many strategies have been tried [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">Kostler et al, 2001</a>].</li><li>Mucositis occurs about 5 to 7 days after chemotherapy, often a few days before the person's haematological lowest point is reached. The mucosal disruption therefore provides a portal of entry for micro-organisms at the time of maximal myelosuppression [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">Davies,&nbsp;2015</a>].</li><li>Spontaneous gingival bleeding is likely to occur when there is a thrombocytopenia [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">Davies,&nbsp;2015</a>].</li><li>Mucositis due to radiotherapy is self-limited and heals within 2 to 3 weeks of the end of radiation treatment [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">Davies,&nbsp;2015</a>].</li></ul><!-- end field 5369e730-2e2f-467f-8a0c-9b0ee60b5117 --><!-- end item 3a03ba12-f0ee-4e52-8bbc-2b769743f376 -->","subChapters":[]}]},{"id":"921b8cad-9cbe-57c9-8c27-4c2984e4b613","slug":"oral-herpes-simplex-infection","fullItemName":"Oral herpes simplex infection","depth":3,"htmlHeader":"<!-- begin field f8be9015-184c-410a-9ae3-3cdb4a0728c5 --><h3>Oral herpes simplex infection</h3><!-- end field f8be9015-184c-410a-9ae3-3cdb4a0728c5 -->","summary":null,"htmlStringContent":"<!-- begin item 85a0d527-f951-4bf5-a6bb-d303fbed5f82 --><!-- begin field f6494f1b-3701-4cdd-a662-9fffdebabdec --><ul><li>Advise bed rest, maintenance of adequate fluid intake and use of antipyretics where necessary.</li><li><strong>In immunocompetent people who are in the early stages of an uncomplicated herpes simplex infection in the locality of the lips, </strong>commence topical aciclovir or penciclovir.<ul><li>Aciclovir 5% cream, apply to cold sore every four hours, five times a day for 5 days.</li><li>Penciclovir 1% cream, apply to cold sore every 2 hours (during waking hours) for 4 days.</li></ul></li><li><strong>In immunocompetent people who are in the early stages of an intraoral herpes infection, </strong>commence oral aciclovir 200 mg tablets five times a day for 5 days.</li><li><strong>In immunocompromised people </strong>urgently commence oral aciclovir 400 mg tablets five times a day for 5 days wherever the herpes simplex infection is located.</li><li>Prevent secondary infection with regular mouth care. Twice-daily chlorhexidine mouthwashes can also be used in the short term but may not be suitable for all people, as the alcohol content can sting. See <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-oral/management/prevention/#choice-of-mouthwash\">Choice of mouthwash</a> for more information.</li><li>Treat the pain of the ulcer (see <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-oral/management/oral-pain/\">Scenario: Oral pain</a> for further information).</li><li>Admit people with severe infection or people who are severely immunocompromised.</li></ul><!-- end field f6494f1b-3701-4cdd-a662-9fffdebabdec --><!-- end item 85a0d527-f951-4bf5-a6bb-d303fbed5f82 -->","subChapters":[{"id":"38ab5a9a-1cce-5351-bc4d-fab0ca1e486d","slug":"basis-for-recommendation-fb6","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 11e226fd-294e-4207-a0e1-b0b6993d0a0d --><h4>Basis for recommendation</h4><!-- end field 11e226fd-294e-4207-a0e1-b0b6993d0a0d -->","summary":null,"htmlStringContent":"<!-- begin item fb692709-4afd-4cce-91ed-e11c4a2504c9 --><!-- begin field 8ad810cb-6c28-4a25-bf57-3cc41924c4e7 --><p>This recommendation is based on published expert opinion [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">Davies and Finlay, 2005</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">Davies,&nbsp;2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">Regnard, 2010</a>], and the manufacturers' Summary of Product Characteristics [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">ABPI Medicines Compendium, 2015</a>].</p><ul><li>Aciclovir or penciclovir should be applied as early as possible in the development of a cold sore, preferably at the prodrome to increase the chance of shortening the course of the infection and reducing the severity of symptoms.</li></ul><!-- end field 8ad810cb-6c28-4a25-bf57-3cc41924c4e7 --><!-- end item fb692709-4afd-4cce-91ed-e11c4a2504c9 -->","subChapters":[]}]},{"id":"2dcc29bc-665e-5094-8b91-9294581bb9ba","slug":"malodorous-malignant-oral-ulcers","fullItemName":"Malodorous malignant oral ulcers","depth":3,"htmlHeader":"<!-- begin field fa8279c1-788c-4122-863a-72cc6816d42e --><h3>Malodorous malignant oral ulcers</h3><!-- end field fa8279c1-788c-4122-863a-72cc6816d42e -->","summary":null,"htmlStringContent":"<!-- begin item 6e758a3b-3c69-4322-8837-3aaaa6909946 --><!-- begin field 358b1e75-058a-4363-a7d3-3cd90d2d7e5a --><p> Ensure effective wound cleansing through regular mouth care. For more information, see <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-oral/management/prevention/\">Scenario: Prevention</a>.</p><ul><li>If anaerobic organisms are present (as indicated by a foul smell), metronidazole is recommended. Discuss the dose and length of treatment with a specialist. Long-term use of metronidazole may be appropriate in some people.</li><li>For bleeding ulcers, seek the advice of a specialist.<ul><li>Using sucralfate suspension 1 g (5 mL) diluted with 5 mL water as a mouthwash may be an option for use with bleeding ulcers, but this unlicensed use is recommended by few experts.</li></ul></li><li>Treat the pain of the ulcer (see <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-oral/management/oral-pain/\">Scenario: Oral pain</a> for further information).</li></ul><!-- end field 358b1e75-058a-4363-a7d3-3cd90d2d7e5a --><!-- end item 6e758a3b-3c69-4322-8837-3aaaa6909946 -->","subChapters":[{"id":"d22458d3-a848-59c7-8049-d8f2a593e08a","slug":"basis-for-recommendation-f88","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 2e033236-b28a-459e-a01b-d7f920b3ed00 --><h4>Basis for recommendation</h4><!-- end field 2e033236-b28a-459e-a01b-d7f920b3ed00 -->","summary":null,"htmlStringContent":"<!-- begin item f88a97ec-64b2-4d45-82ab-c4b1282db962 --><!-- begin field 579d1df6-4d0c-47a0-8717-e1ee1ab7f4ce --><p>CKS recommends discussing management with a specialist as expert opinion is divided on the dose and duration of metronidazole treatment [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">O'Neill and Fallon, 1997</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">Twycross et al, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">Davies,&nbsp;2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">Regnard, 2010</a>].</p><h5>Anaerobic organisms</h5><ul><li><strong>Metronidazole </strong>is active against anaerobic organisms. Although there are no studies of its use in malignant ulcers in the oral cavity, some small studies in cutaneous malignant ulcers found a marked reduction in odour [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">Sparrow et al, 1980</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">Ashford et al, 1984</a>].</li><li><strong>Treatment may need to be continued over the long term, </strong>as the odour usually returns when treatment is stopped. There is no evidence that the effectiveness of metronidazole decreases with prolonged or repeated use. Resistance to metronidazole by the odour-producing anaerobes is unlikely to develop [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">UKMI, 2002</a>].</li></ul><h5>Bleeding ulcers</h5><ul><li>The recommendation on management of bleeding ulcers is based on expert opinion in a palliative care textbook [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">Regnard, 2010</a>].</li></ul><!-- end field 579d1df6-4d0c-47a0-8717-e1ee1ab7f4ce --><!-- end item f88a97ec-64b2-4d45-82ab-c4b1282db962 -->","subChapters":[]}]},{"id":"edea12f8-7ca8-5627-8948-bdcd0eaa4782","slug":"neutropenic-ulcers","fullItemName":"Neutropenic ulcers","depth":3,"htmlHeader":"<!-- begin field a95f37ea-648b-4815-8623-6fbbbaf022ad --><h3>Neutropenic ulcers</h3><!-- end field a95f37ea-648b-4815-8623-6fbbbaf022ad -->","summary":null,"htmlStringContent":"<!-- begin item 936a0b44-ab8f-4888-88e4-0372098f4df6 --><!-- begin field 5aa074f4-7bef-428e-a63a-298a70946530 --><ul><li>Seek urgent specialist advice if neutropenia is suspected from the appearance of the ulcer (see <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-oral/diagnosis/examination/#clinical-features-of-types-of-mouth-ulcers\">Clinical features of types of mouth ulcers</a>) or if confirmed by a blood test.</li></ul><!-- end field 5aa074f4-7bef-428e-a63a-298a70946530 --><!-- end item 936a0b44-ab8f-4888-88e4-0372098f4df6 -->","subChapters":[{"id":"5cbfca2a-0ae2-504a-a7f6-9b7f4962e060","slug":"basis-for-recommendation-4fb","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 4d99421c-6c15-4582-9e1b-d70b2203d15d --><h4>Basis for recommendation</h4><!-- end field 4d99421c-6c15-4582-9e1b-d70b2203d15d -->","summary":null,"htmlStringContent":"<!-- begin item 4fbff9f6-0b47-4198-b2c6-9174e74c8b42 --><!-- begin field a570cc98-e238-43d5-afba-6516c1a8af79 --><p>The basis for this recommendation is pragmatic advice.</p><ul><li>Recovery of the neutrophil count is needed for healing [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-oral/references/\">Davies,&nbsp;2015</a>].</li></ul><!-- end field a570cc98-e238-43d5-afba-6516c1a8af79 --><!-- end item 4fbff9f6-0b47-4198-b2c6-9174e74c8b42 -->","subChapters":[]}]},{"id":"66a9ccaa-8466-5287-85da-be09016b743b","slug":"referral","fullItemName":"Referral","depth":3,"htmlHeader":"<!-- begin field 300623d5-9484-4c0c-a421-43995e8fbddb --><h3>Referral</h3><!-- end field 300623d5-9484-4c0c-a421-43995e8fbddb -->","summary":null,"htmlStringContent":"<!-- begin item e325c0e4-dea1-46a2-8584-8efa1a326e8d --><!-- begin field fccc08f6-c72b-4cba-b635-cc7cde82ce3a --><ul><li>Refer or seek specialist advice if there is doubt about diagnosis or management of any oral problem. Refer if:<ul><li>Oral problems are causing a decrease in oral intake or there are concerns about nutrition.</li><li>Mucositis is uncontrolled or problematic. See <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-oral/management/mouth-ulcers-mucositis/#mucositis\">Mucositis</a>.</li><li>Neutropenic ulcers and neutropenia are suspected. See <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-oral/management/mouth-ulcers-mucositis/#neutropenic-ulcers\">Neutropenic ulcers</a>.</li><li>Oral ulcers are bleeding.</li><li>Taste disturbance is likely to be prolonged. Refer to a dietitian.</li><li>Pain is difficult to manage.</li><li>There is severe candida infection. See <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-oral/management/oral-candida-infection/\">Scenario: Oral candida infection</a>.</li><li>There are communication problems. Consider referral to a speech and language therapist.</li></ul></li></ul><!-- end field fccc08f6-c72b-4cba-b635-cc7cde82ce3a --><!-- end item e325c0e4-dea1-46a2-8584-8efa1a326e8d -->","subChapters":[{"id":"018b2aa2-be3f-53a6-ac02-69abe5ace235","slug":"basis-for-recommendation-959","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 311945fd-e21b-4fec-acd8-98b45b4e7461 --><h4>Basis for recommendation</h4><!-- end field 311945fd-e21b-4fec-acd8-98b45b4e7461 -->","summary":null,"htmlStringContent":"<!-- begin item 9594f297-e4c3-4083-acf3-403bfb0b2bfb --><!-- begin field feb6c7d4-329b-4477-bfdf-59088d62eb09 --><p>These recommendations are based on standard clinical practice.</p><!-- end field feb6c7d4-329b-4477-bfdf-59088d62eb09 --><!-- end item 9594f297-e4c3-4083-acf3-403bfb0b2bfb -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}